Parameters for Holding Diltiazem (Cardizem) Due to Hypotension
Diltiazem should be held if systolic blood pressure is less than 90 mmHg, as this is a contraindication according to FDA labeling. 1
Blood Pressure Parameters
- Hold diltiazem if systolic blood pressure is less than 90 mmHg (hypotension) 1
- Use with caution in patients with borderline blood pressure (90-100 mmHg systolic) due to risk of significant hypotension 2
- Monitor blood pressure closely after administration, as hypotension is the most common adverse effect 2
- Consider holding diltiazem in patients with decompensated heart failure, as it may worsen hypotension in these patients 3
Cardiac Parameters
- Hold diltiazem in patients with:
- Sick sinus syndrome (unless patient has functioning ventricular pacemaker) 1
- Second or third-degree AV block (unless patient has functioning ventricular pacemaker) 1
- Acute myocardial infarction with pulmonary congestion 1
- Decompensated systolic heart failure or severe left ventricular dysfunction 3, 2
- Cardiogenic shock 3
Management of Diltiazem-Induced Hypotension
If hypotension occurs after diltiazem administration:
- Administer vasopressors (e.g., dopamine or norepinephrine) 1
- Consider intravenous fluids if not contraindicated 1
- For severe cases, calcium administration may help reverse calcium channel blocker effects:
Dosing Considerations to Minimize Hypotension Risk
- Consider using lower initial doses of diltiazem (≤0.2 mg/kg IV) in patients at risk for hypotension, as this has been shown to be as effective as standard dosing with lower hypotension risk 4
- For IV administration, standard dosing is 0.25 mg/kg over 2 minutes, with maintenance infusion at 5-15 mg/hour 3
- For oral administration, initial doses typically start at 120 mg daily, with maximum maintenance doses of 360 mg daily 2
Special Populations at Higher Risk
- Elderly patients are more susceptible to hypotension with diltiazem 2
- Patients with hepatic or renal dysfunction may have altered metabolism of diltiazem, increasing hypotension risk 3
- Patients taking other medications with SA and/or AV nodal-blocking properties have increased risk of bradycardia and hypotension 3
- Patients with Wolff-Parkinson-White syndrome with atrial fibrillation/flutter should not receive diltiazem 3
Drug Interactions That May Worsen Hypotension
- Use caution when combining diltiazem with beta-blockers due to increased risk of bradyarrhythmias and heart failure 3, 5
- Diltiazem is a CYP3A4 substrate and moderate inhibitor; use caution with medications metabolized through this pathway 3, 2
- Avoid routine use with other medications that can cause hypotension 2